In this series, the clinical features, immunophenotype, and overall survival were not different between PTCL, NOS cases with leukemic involvement (TCL1-family-negative), or T-PLL (TCL1-family-positive) cases. This evidence concerns the gene TCL1A and mature T-cell and NK-cell non-Hodgkin lymphoma.